Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jul;39(3):399-405.
doi: 10.5534/wjmh.200065. Epub 2020 Jul 8.

The Natural History of Peyronie's Disease

Affiliations
Review

The Natural History of Peyronie's Disease

Fabrizio Di Maida et al. World J Mens Health. 2021 Jul.

Abstract

Peyronie's disease (PD), a fibrotic disorder of the tunica albuginea fully described in 1793 by French physician Francois de la Peyronie, is characterized by pain, plaque formation, penile deformity, and ultimately sexual function decline. The epidemiological data on PD vary considerably across previous studies, with recent evidence reporting a prevalence of up to 9%. PD is generally divided into two different phases: active or acute and stable or chronic. Plaque formation generally occurs during the acute phase, while during chronic phase pain usually tends to complete resolution and penile deformity stabilizes. PD's pathophysiology is still subject of great discussion. Tunical mechanical stress and microvascular trauma are major contributory factors. However, better understanding of the molecular pathophysiology of this condition remains paramount towards an in-depth comprehension of the disorder and the development of newer and more effective disease-targeted interventions. In this review we provide a detailed overview of natural history of PD, specifically focusing on clinical manifestations and the underlying molecular regulation patterns.

Keywords: Natural history; Penile diseases; Penile erection; Penile induration.

PubMed Disclaimer

Conflict of interest statement

The authors have nothing to disclose.

References

    1. Ziegelmann MJ, Bajic P, Levine LA. Peyronie's disease: contemporary evaluation and management. Int J Urol. 2020;27:504–516. - PubMed
    1. Musitelli S, Bossi M, Jallous H. A brief historical survey of “Peyronie's disease”. J Sex Med. 2008;5:1737–1746. - PubMed
    1. Capoccia E, Levine LA. Contemporary review of Peyronie's disease treatment. Curr Urol Rep. 2018;19:51. - PubMed
    1. Cocci A, Russo GI, Briganti A, Salonia A, Cacciamani G, Capece M, et al. Predictors of treatment success after collagenase clostridium histolyticum injection for Peyronie's disease: development of a nomogram from a multicentre single-arm, non-placebo controlled clinical study. BJU Int. 2018;122:680–687. - PubMed
    1. Rosen R, Catania J, Lue T, Althof S, Henne J, Hellstrom W, et al. Impact of Peyronie's disease on sexual and psychosocial functioning: qualitative findings in patients and controls. J Sex Med. 2008;5:1977–1984. - PubMed